No apparent alteration of F-18 FDG biodistribution when injected shortly after insulin glargine

Clin Nucl Med. 2007 Apr;32(4):302-3. doi: 10.1097/01.rlu.0000257273.55996.8b.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Artifacts*
  • Drug Interactions
  • Female
  • Fluorodeoxyglucose F18 / administration & dosage
  • Fluorodeoxyglucose F18 / pharmacokinetics*
  • Humans
  • Injections, Intravenous
  • Insulin / administration & dosage
  • Insulin / analogs & derivatives*
  • Insulin Glargine
  • Insulin, Long-Acting
  • Metabolic Clearance Rate / drug effects
  • Positron-Emission Tomography*
  • Radiopharmaceuticals / pharmacokinetics
  • Tissue Distribution / drug effects
  • Whole Body Imaging*

Substances

  • Insulin
  • Insulin, Long-Acting
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Insulin Glargine